Geode Capital Management
PAND

Geode Capital Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Geode Capital Management’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-181,708
Closed -$10.9M – 4782
2021
Q1 		$10.9M Buy
181,708
+92,830
+104% +$3.36M ﹤0.01% 2299
2020
Q4 		$1.32M Buy
88,878
+19,129
+27% +$266K ﹤0.01% 3275
2020
Q3 		$799K Buy
+69,749
New +$1.19M ﹤0.01% 3289

Geode Capital Management's PAND Position: Q2 2021 in Review

Geode Capital Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 181,708 shares — an estimated $10.9M sold.

Geode Capital Management first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $10.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Geode Capital Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Geode Capital Management sold 181,708 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $10.9M.
  • Geode Capital Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Geode Capital Management's Pandion Therapeutics Inc. Common Stock position peaked at $10.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.